← Back to headlines
Eli Lilly's New GLP-1 Pill and Stock Valuation Prospects
The article discusses whether Eli Lilly's new GLP-1 pill could drive the company's stock valuation back to the $1 trillion mark, examining its market potential.
20 Apr, 14:35 — 20 Apr, 14:35
Sources
Showing 1 of 1 sources
